Does longer peripheral intravenous catheter length optimise antimicrobial delivery? Protocol for the LEADER study.
Randomised controlled trial
Study protocol
Vascular access
Journal
British journal of nursing (Mark Allen Publishing)
ISSN: 0966-0461
Titre abrégé: Br J Nurs
Pays: England
ID NLM: 9212059
Informations de publication
Date de publication:
06 Apr 2023
06 Apr 2023
Historique:
medline:
11
4
2023
entrez:
7
4
2023
pubmed:
8
4
2023
Statut:
ppublish
Résumé
Hospitalised patients receiving intravenous antimicrobial therapy require a reliable device through which this is delivered. Short peripheral intravenous catheters (PIVCs) are the default device for antimicrobial therapy but up to half fail before therapy completion, leading to suboptimal drug dosing, patient distress from repeated insertions, and increased healthcare costs. This study will investigate the use of long PIVCs to determine if they are more reliable at delivering antimicrobial therapy. A two-arm, parallel randomised controlled trial of hospitalised adults requiring at least 3 days of peripherally compatible intravenous antimicrobials. Participants will be randomised to a short (<4 cm) or long (4.5-6.4 cm) PIVC. After interim analysis (
Sections du résumé
BACKGROUND
BACKGROUND
Hospitalised patients receiving intravenous antimicrobial therapy require a reliable device through which this is delivered. Short peripheral intravenous catheters (PIVCs) are the default device for antimicrobial therapy but up to half fail before therapy completion, leading to suboptimal drug dosing, patient distress from repeated insertions, and increased healthcare costs. This study will investigate the use of long PIVCs to determine if they are more reliable at delivering antimicrobial therapy.
METHODS
METHODS
A two-arm, parallel randomised controlled trial of hospitalised adults requiring at least 3 days of peripherally compatible intravenous antimicrobials. Participants will be randomised to a short (<4 cm) or long (4.5-6.4 cm) PIVC. After interim analysis (
Identifiants
pubmed: 37027419
doi: 10.12968/bjon.2023.32.7.S24
doi:
Substances chimiques
Anti-Infective Agents
0
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng